Sana Biotechnology Inc (SANA)
2.61
+0.26
(+11.06%)
USD |
NASDAQ |
Nov 22, 16:00
2.68
+0.07
(+2.68%)
After-Hours: 20:00
Sana Biotechnology Total Assets (Quarterly): 559.39M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 559.39M |
| June 30, 2024 | 618.67M |
| March 31, 2024 | 681.38M |
| December 31, 2023 | 565.30M |
| September 30, 2023 | 631.44M |
| June 30, 2023 | 707.15M |
| March 31, 2023 | 746.93M |
| December 31, 2022 | 822.72M |
| September 30, 2022 | 898.10M |
| Date | Value |
|---|---|
| June 30, 2022 | 971.09M |
| March 31, 2022 | 1.048B |
| December 31, 2021 | 1.129B |
| September 30, 2021 | 1.233B |
| June 30, 2021 | 1.260B |
| March 31, 2021 | 1.304B |
| December 31, 2020 | 730.30M |
| September 30, 2020 | 767.72M |
| December 31, 2019 | 415.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
415.19M
Minimum
Dec 2019
1.304B
Maximum
Mar 2021
838.30M
Average
757.32M
Median
Total Assets (Quarterly) Benchmarks
| Foghorn Therapeutics Inc | 308.37M |
| Omega Therapeutics Inc | 152.73M |
| Moderna Inc | 15.80B |
| Summit Therapeutics Inc | 502.85M |
| Apellis Pharmaceuticals Inc | 901.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 266.91M |
| Shareholders Equity (Quarterly) | 292.48M |